"10.1371_journal.pone.0102274","plos one","2014-07-14T00:00:00Z","Vitaly A Kushnir; Yao Yu; David H Barad; Andrea Weghofer; Eric Himaya; Ho-Joon Lee; Yan-Guang Wu; Aya Shohat-Tal; Emanuela Lazzaroni-Tealdi; Norbert Gleicher","Center for Human Reproduction, New York, New York, United States of America; Foundation for Reproductive Medicine, New York, New York, United States of America; Department of Obstetrics and Gynecology, University of Vienna School of Medicine, Vienna, Austria; Gatineau Hospital, McGill University, Quebec, Canada","Conceived and designed the experiments: VAK DHB NG. Performed the experiments: EH YY AW DHB HJL YGW AST ELT. Analyzed the data: VAK EH YY AW DHB NG. Contributed reagents/materials/analysis tools: EH YY AW DHB HJL YGW AST ELT. Wrote the paper: VAK NG.","Additionally, the authors have read the journals policy and have the following conflicts: Dr. Barad and Dr. Gleicher are co-inventors of a number of pending patents, claiming diagnostic benefits from evaluations of CGGn on the FMR1 gene. This data was partially presented at the 69th Annual Meeting of the American Society for Reproductive Medicine in Boston, MA, on October 14â€17, 2013. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Vitaly A Kushnir","VAK",10,TRUE,3,8,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
